Stay updated with breaking news from 03664210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Antares Pharma (NASDAQ:ATRS – Get Rating) in a research note published on Thursday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. ATRS has been the topic of a number of other research reports. HC Wainwright reaffirmed a buy rating and set a $5.00 target […]
Russell Investments Group Ltd. increased its stake in Antares Pharma, Inc. (NASDAQ:ATRS – Get Rating) by 226.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,142,491 shares of the specialty pharmaceutical company’s stock after acquiring an additional 792,898 shares during the quarter. Russell Investments […]
Antares Pharma, Inc. (NASDAQ:ATRS – Get Rating) shares saw unusually-high trading volume on Wednesday . Approximately 24,287 shares traded hands during trading, a decline of 97% from the previous session’s volume of 733,032 shares.The stock last traded at $4.10 and had previously closed at $3.94. ATRS has been the topic of a number of recent […]